Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population
- PMID: 31124510
- PMCID: PMC6552624
- DOI: 10.4103/ijo.IJO_1030_17
Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population
Abstract
Purpose: To analyze and report outcomes of microincision vitrectomy surgery (MIVS) for Stage 4 and 5 retinopathy of prematurity (ROP).
Methods: Medical records of 202 eyes of 129 premature children undergoing MIVS for Stage 4/Stage 5 ROP between January 2012 and April 2015 were evaluated. The primary outcome measure was the proportion of eyes with anatomical success (defined as attached retina at the posterior pole at last follow-up). Complications associated with MIVS were noted and analysis of risk factors associated with poor anatomical outcome was also done using logistic regression.
Results: Mean age of presentation of babies with Stage 4 ROP (2.9 ± 1.75 months) was lower than those with stage 5 disease (5.62 ± 2.55 months) (P < 0.005). One hundred seventeen eyes (56% or 58%) had Stage 5, 38 (19%) had Stage 4a, and 47 (23%) Stage 4b. Ninety-four eyes (47%) had received prior treatment (laser and/or anti-vascular endothelial growth factors [VEGF]). Lens-sparing vitrectomy (LSV) was performed in 58 (29%) eyes while lensectomy with vitrectomy (LV) was performed in 144 (71%) eyes. At a mean follow-up of 32.5 weeks, 102 (50.5%) eyes achieved anatomical success, including 74% eyes in Stage 4a and 4b and 33% in Stage 5. Complications included intraoperative break formation (19%), postoperative vitreous hemorrhage (28%), raised intraocular pressure (12.7%), and cataract progression (2.4%). Factors significantly associated with favorable anatomical outcome were Stage 4 disease (vs. Stage 5) (odds ratio [OR] 5.8; confidence interval [CI] =2.6-13.8, P < 0.005), prior treatment (laser ± anti-VEGF) (OR 2.5; CI 1.4-4.7, P < 0.005) surgery with 25G MIVS (vs. 23G) (OR: 1.7; CI = 0.98-3.00, P = 0.05) and LSV (vs. LV) (OR 7; CI = 3.4-14.6, P < 0.005). Retinal break was significantly associated with poor anatomical outcome (OR 0.21; CI = 0.09-0.5, P < 0.005).
Conclusion: MIVS along with wide angle viewing systems allow surgeons to effectively manage ROP surgeries while at the same time reducing complication rate in these eyes which have complex pathoanatomy and otherwise grim prognosis.
Keywords: Microincision vitrectomy surgery; Stage 4; Stage 5; retinal detachment; retinopathy of prematurity; surgical outcome; vitrectomy.
Conflict of interest statement
None
Figures

Similar articles
-
Surgical outcomes in aggressive retinopathy of prematurity (AROP)-related retinal detachments.Indian J Ophthalmol. 2023 Nov;71(11):3454-3459. doi: 10.4103/IJO.IJO_2999_22. Indian J Ophthalmol. 2023. PMID: 37870006 Free PMC article.
-
Parameters affecting postoperative success of surgery for stage 4A/4B ROP.Br J Ophthalmol. 2019 Nov;103(11):1624-1632. doi: 10.1136/bjophthalmol-2018-312922. Epub 2019 Jan 18. Br J Ophthalmol. 2019. PMID: 30658990
-
ANATOMICAL AND VISUAL OUTCOMES IN STAGE 5 RETINOPATHY OF PREMATURITY WITH MICROINCISION VITRECTOMY SURGERY.Retina. 2021 Feb 1;41(2):331-337. doi: 10.1097/IAE.0000000000002837. Retina. 2021. PMID: 32349102
-
Primary scleral buckling vs. vitrectomy for stage 4A retinopathy of prematurity: a systematic review and meta-analysis of surgical outcomes.Eye (Lond). 2025 Feb;39(3):418-423. doi: 10.1038/s41433-024-03563-7. Epub 2025 Jan 2. Eye (Lond). 2025. PMID: 39748110
-
[Outcomes of surgical management of retinopathy of prematurity--an overview].Klin Oczna. 2014;116(2):138-41. Klin Oczna. 2014. PMID: 25345295 Review. Polish.
Cited by
-
Surgical outcomes in aggressive retinopathy of prematurity (AROP)-related retinal detachments.Indian J Ophthalmol. 2023 Nov;71(11):3454-3459. doi: 10.4103/IJO.IJO_2999_22. Indian J Ophthalmol. 2023. PMID: 37870006 Free PMC article.
-
Staged lensectomy and vitrectomy in the management of stage 5C retinopathy of prematurity with corneal opacification: long-term follow up.Int J Ophthalmol. 2022 Sep 18;15(9):1437-1443. doi: 10.18240/ijo.2022.09.05. eCollection 2022. Int J Ophthalmol. 2022. PMID: 36124179 Free PMC article.
-
Anatomic and Functional Outcomes of Vitrectomy for Advanced Retinopathy of Prematurity: A Systematic Review.J Ophthalmic Vis Res. 2024 Jun 21;19(2):246-254. doi: 10.18502/jovr.v19i2.14027. eCollection 2024 Apr-Jun. J Ophthalmic Vis Res. 2024. PMID: 39055508 Free PMC article. Review.
References
-
- Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106:471–9. - PubMed
-
- Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77–82. - PubMed
-
- Kuprjanowicz L, Kubasik-Kładna K, Modrzejewska M. Outcomes of surgical management of retinopathy of prematurity – An overview. Klin Oczna. 2014;116:138–41. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous